Revolutionizing healthcare one cell at a time.

IncellDx is a molecular diagnostics company dedicated to revolutionizing healthcare one cell at a time. By combining molecular diagnostics with high throughput cellular analysis, we focus on critical life threatening diseases such as HIV/AIDs, HPV/Cervical Cancer, Hepatitis, organ transplant infections, breast cancer and ovarian cancer.

Our proprietary diagnostic method provides specific molecular details about each and every cell. This technology now made available through IncellDx, is capable of revolutionizing the field of molecular diagnostics, one cell at a time.

Learn More

NEW: IncellDx Signs Agreement with Bristol-Myers Squibb Related to the Development of an Assay for a Companion Diagnostic Test

 

Research article on PLOS One: ‘mRNA and DNA Detection of Human Papillomaviruses in Women of All Ages Attending Two Colposcopy Clinics.*
*HPV OncoTect is CE-IVD marked, not registered in the US
Download PDF.

Read our editorial in Future Virology on the utility of our HIV Viral Reservoirs Assay: http://www.futuremedicine.com/doi/full/10.2217/fvl.12.72 as well as our recent HIV Viral Reservoir research publication referenced in our HIV/AIDS literature citing work using the HIV Viral Reservoir Assay: http://incelldx.com/products/literature/

 

 

IncellDx Receives the 2012 North American Product Leadership Award in the Molecular Diagnostics Market from Frost & Sullivan

 

 

  

IncellDx signs its first CDx Agreement

Bristol-Meyers Squibb and IncellDx have entered into an agreement to develop a companion diagnostic assay around IncellDx’s quantitative InCellCept technology which is intended to identify patients likely to benefit from treatment with a drug that is currently under development.
Read more: IncellDx Signs Agreement with Bristol-Myers Squibb

Journal of Clinical Microbiology publishes New HIV article by IncellDx.

The Journal of Clinical Microbiology has published an early release of IncellDx’s new article,”Identification and Characterization of HIV-1 Latent Viral Reservoirs In Peripheral Blood” online.
Read more: Identification and Characterization of HIV-1 Latent Viral Reservoirs In Peripheral Blood

Join IncellDx at AMP 2014 in Washington D.C.

IncellDx will be at the 2014 AMP Conference. Visit us at both #1101 and view our corporate symposium on November 12th, 2014 at 3:00pm – 4:00pm
Read more: AMP 2014